RecruitingNot ApplicableNCT07011862
COBRA: Cancer, Older Adults, Balance and Resistance Activities
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
38 participants
Start Date
May 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.
Eligibility
Min Age: 65 Years
Inclusion Criteria12
- Older Adult Patients with Cancer
- \- Are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
- For the purpose of this study, primary therapy is defined as treatment of curative intent, first-line or later, from which the individual is advancing to active surveillance or follow-up with or without maintenance therapy.
- Individuals with metastatic cancer may be included provided they have stable disease or better per most recent restaging exam at time of enrollment.
- i. Patients with stable metastatic bony disease at most recent restaging exam and a score of 0-2 on the Functional Pain Scale (FPS69; Appendix 18) are eligible. The PI will consult with the Rehab Med co-PI for FPS scores of 3 or greater, by patient request or PI discretion.
- ii. Patients with symptomatic visceral metastases will be evaluated on a case-by-case basis at time of enrollment.
- Are aged 65 years and older, with no upper age limit;
- ECOG PS 0-3 or Karnofsky PS greater than or equal to 40;
- Can read and speak English;
- Self-report access to internet connection sufficient to support videoconferencing.
- Clinicians
- Licensed clinician (MD, RN, APP) with an interest in the care of older adults with cancer.
Exclusion Criteria5
- Older Adult Patients with Cancer
- Have any cognitive impairment, neurologic, musculoskeletal, or other comorbid condition (as assessed by their provider) that would prevent the individual from engaging with the digital health coaching program or complete study assessments or engage in progressive intensity levels of physical activity
- Have a neurologic, musculoskeletal, or other comorbid condition that would impede their ability to safely engage in progressive intensity levels of physical activity (as assessed by their provider). Patients with metastatic disease and suspected interim progression since last restaging exam will be referred back to their primary oncology care team for evaluation prior to enrollment.
- Have activity restrictions post-surgery at the time of enrollment
- Clinicians No expected exclusions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALCancer, Older adults, Balance and Resistance Activities
The COBRA intervention is delivered as a web-based application through an iPad configured to allow access only to the study application and Zoom videoconferencing icons during the trial.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07011862
Related Trials
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Patient-Centered Assessment of Symptoms and Outcomes
NCT039526241 location
Tumor Related Epilepsy
NCT026393251 location
Improving Engagement in HIV and Cancer Care in Zimbabwe
NCT069343691 location
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
NCT074543307 locations